Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 26 (3), 175-185
- https://doi.org/10.1016/s0169-5002(99)00089-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancerBritish Journal of Cancer, 1997
- Extensive and saturable accumulation of paclitaxel by the human plateletCancer Chemotherapy and Pharmacology, 1995
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.Journal of Clinical Oncology, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- The New International Staging System for Lung CancerSurgical Clinics of North America, 1987
- Reporting results of cancer treatmentCancer, 1981
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958